Relationship between weight loss in obese knee osteoarthritis patients and serum biomarkers of cartilage breakdown: secondary analyses of a randomised trial
Bartels, E. M.; Henrotin, Yves; Bliddal, H.et al.
2017 • In Osteoarthritis and Cartilage, 25 (10), p. 1641-1646
Bartels, E. M.; The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark
Henrotin, Yves ; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartilage (U.R.O.C.)
Bliddal, H.; The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, Faculty of Health Science, University of Copenhagen, Denmark
Centonze, Prescilia ; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartilage (U.R.O.C.)
Henriksen, M.; The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, Department of Physical and Occupational Therapy, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark
Language :
English
Title :
Relationship between weight loss in obese knee osteoarthritis patients and serum biomarkers of cartilage breakdown: secondary analyses of a randomised trial
Publication date :
2017
Journal title :
Osteoarthritis and Cartilage
ISSN :
1063-4584
eISSN :
1522-9653
Publisher :
W.B. Saunders Ltd
Volume :
25
Issue :
10
Pages :
1641-1646
Peer reviewed :
Peer Reviewed verified by ORBi
European Projects :
FP7 - 305815 - D-BOARD - Novel Diagnostics and Biomarkers for Early Identification of Chronic Inflammatory Joint Diseases
Lohmander, L.S., Lark, M.W., Dahlberg, L., Walakovits, L.A., Roos, H., Cartilage matrix metabolism in osteoarthritis: markers in synovial fluid, serum, and urine. Clin Biochem 25 (1992), 167–174.
McAlindon, T.E., Driban, J.B., Lo, G.H., Osteoarthritis year 2011 in review: clinical. Osteoarthritis Cartilage 20 (2012), 197–200.
Gudbergsen, H., Boesen, M., Lohmander, L.S., Christensen, R., Henriksen, M., Bartels, E.M., et al. Weight loss is effective for symptomatic relief in obese subjects with knee osteoarthritis independently of joint damage severity assessed by high-field MRI and radiography. Osteoarthritis Cartilage 20 (2012), 495–502.
Gudbergsen, H., Boesen, M., Christensen, R., Astrup, A., Bliddal, H., Radiographs and low field MRI (0.2T) as predictors of efficacy in a weight loss trial in obese women with knee osteoarthritis. BMC Musculoskelet Disord, 12, 2011, 56.
Riis, R.G., Gudbergsen, H., Henriksen, M., Ballegaard, C., Bandak, E., Rottger, D., et al. Synovitis assessed on static and dynamic contrast-enhanced magnetic resonance imaging and its association with pain in knee osteoarthritis: a cross-sectional study. Eur J Radiol 85 (2016), 1099–1108.
Niu, J., Zhang, Y.Q., Torner, J., Nevitt, M., Lewis, C.E., Aliabadi, P., et al. Is obesity a risk factor for progressive radiographic knee osteoarthritis?. Arthritis Rheum 61 (2009), 329–335.
Bartels, E.M., Christensen, R., Christensen, P., Henriksen, M., Bennett, A., Gudbergsen, H., et al. Effect of a 16 weeks weight loss program on osteoarthritis biomarkers in obese patients with knee osteoarthritis: a prospective cohort study. Osteoarthritis Cartilage 22 (2014), 1817–1825.
Lafeber, F.P., van Spil, W.E., Osteoarthritis year 2013 in review: biomarkers; reflecting before moving forward, one step at a time. Osteoarthritis Cartilage 21 (2013), 1452–1464.
van Spil, W.E., Welsing, P.M., Bierma-Zeinstra, S.M., Bijlsma, J.W., Roorda, L.D., Cats, H.A., et al. The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK. Osteoarthritis Cartilage 23 (2015), 1388–1397.
Deberg, M., Labasse, A., Christgau, S., Cloos, P., Bang, H.D., Chapelle, J.P., et al. New serum biochemical markers (Coll2-1 and Coll2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 13 (2005), 258–265.
Henrotin, Y., Deberg, M., Dubuc, J.E., Quettier, E., Christgau, S., Reginster, J.Y., Type II collagen peptides for measuring cartilage degradation. Biorheology 41 (2004), 543–547.
Deberg, M., Dubuc, J.E., Labasse, A., Sanchez, C., Quettier, E., Bosseloir, A., et al. One-year follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement. Ann Rheum Dis 67 (2008), 168–174.
Verwilghen, D.R., Enzerink, E., Martens, A., Franck, T., Balligand, M., Henrotin, Y., et al. Relationship between arthroscopic joint evaluation and the levels of Coll2-1, Coll2-1NO(2), and myeloperoxidase in the blood and synovial fluid of horses affected with osteochondrosis of the tarsocrural joint. Osteoarthritis Cartilage 19 (2011), 1323–1329.
Henrotin, Y., Gharbi, M., Dierckxsens, Y., Priem, F., Marty, M., Seidel, L., et al. Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial. BMC Complement Altern Med, 14, 2014, 159.
Henrotin, Y., Gharbi, M., Mazzucchelli, G., Dubuc, J.E., De, P.E., Deberg, M., Fibulin3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis. Arthritis Rheum 64 (2012), 2260–2267.
Runhaar, J., Sanchez, C., Taralla, S., Henrotin, Y., Bierma-Zeinstra, S.M., Fibulin-3 fragments are prognostic biomarkers of osteoarthritis incidence in overweight and obese women. Osteoarthritis Cartilage 24 (2016), 672–678.
Xu, J., Mosher, D., Fibronectin and Other Adhesive Glycoproteins. Mecham, (eds.) The Extracellular Matrix, 2011, Springer, New York, 41–75.
Giltay, R., Timpl, R., Kostka, G., Sequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, Fibulin-3 and Fibulin-4. Matrix Biol 18 (1999), 469–480.
Kobayashi, N., Kostka, G., Garbe, J.H., Keene, D.R., Bachinger, H.P., Hanisch, F.G., et al. A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization. J Biol Chem 282 (2007), 11805–11816.
Djokic, J., Fagotto-Kaufmann, C., Bartels, R., Nelea, V., Reinhardt, D.P., Fibulin-3, -4, and -5 are highly susceptible to proteolysis, interact with cells and heparin, and form multimers. J Biol Chem 288 (2013), 22821–22835.
Riecke, B.F., Christensen, R., Christensen, P., Leeds, A.R., Boesen, M., Lohmander, L.S., et al. Comparing two low-energy diets for the treatment of knee osteoarthritis symptoms in obese patients: a pragmatic randomized clinical trial. Osteoarthritis Cartilage 18 (2010), 746–754.
Christensen, R., Henriksen, M., Leeds, A.R., Gudbergsen, H., Christensen, P., Sorensen, T.J., et al. Effect of weight maintenance on symptoms of knee osteoarthritis in obese patients: a twelve-month randomized controlled trial. Arthritis Care Res (Hoboken) 67 (2015), 640–650.
Christensen, P., Bartels, E.M., Riecke, B.F., Bliddal, H., Leeds, A.R., Astrup, A., et al. Improved nutritional status and bone health after diet-induced weight loss in sedentary osteoarthritis patients: a prospective cohort study. EJCN 66 (2011), 504–509.
Roos, E.M., Roos, H.P., Lohmander, L.S., Ekdahl, C., Beynnon, B.D., Knee injury and Osteoarthritis Outcome Score (KOOS)–development of a self-administered outcome measure. J Orthop Sports Phys Ther 28 (1998), 88–96.
Henriksen, M., Christensen, R., Hunter, D.J., Gudbergsen, H., Boesen, M., Lohmander, L.S., et al. Structural changes in the knee during weight loss maintenance after a significant weight loss in obese patients with osteoarthritis: a report of secondary outcome analyses from a randomized controlled trial. Osteoarthritis Cartilage 22 (2014), 639–646.
Henriksen, M., Christensen, R., Danneskiold-Samsoe, B., Bliddal, H., Changes in lower extremity muscle mass and muscle strength after weight loss in obese patients with knee osteoarthritis: a prospective cohort study. Arthritis Rheum 64 (2012), 438–442.
Gudbergsen, H., MRI in knee osteoarthritis. Application in diet intervention. Dan Med J, 60, 2013, B4594.
